IgG4ward! EuroJAM: What to Expect and How to Plan Your Visit
EuroJAM 2026 brings together a global, multidisciplinary faculty to advance care and research in IgG4-related disease (IgG4-RD). Spanning 10+ specialties, the meeting reflects the collaborative approach required for accurate diagnosis and effective management. Explore the program and register to join the conversation in London.
Why EuroJAM?
IgG4-related disease is a complex condition that often spans multiple organ systems, requiring input from a wide range of specialties.
The EuroJAM is designed to reflect this reality - bringing together experts across disciplines to support more accurate diagnosis, coordinated care, and improved patient outcomes.
By creating space for collaboration between clinicians, researchers, and the broader community, the meeting aims to bridge gaps between specialties and translate knowledge into real-world practice.
Featured Faculty:
EuroJAM brings together an exceptional, multidisciplinary faculty from around the world spanning both clinical care and cutting-edge research in IgG4-related disease.
The EuroJAM faculty includes:
Dr Emanuel Della Torre – International leader in IgG4-RD pathogenesis and treatment
Dr Matthias Löhr – Global authority in pancreatic disease and translational research
Dr Maria Leandro – Specialist in systemic and renal manifestations of autoimmune disease
Dr Claire Rice – Neurology expert, highlighting the complexity of IgG4-RD across organ systems
EuroJAM’s faculty spans the full spectrum of specialties involved in IgG4-RD care, including pancreatology, hepatology, nephrology, rheumatology, endocrinology, neurology, urology, ENT, dermatology, and general internal medicine.
This breadth reflects the multidisciplinary collaboration required to accurately diagnose and effectively manage this complex condition.
Together, this faculty positions EuroJAM as a leading forum for advancing clinical care, research, and collaboration in IgG4-related disease worldwide.
Program Overview:
Across two days, EuroJAM will feature keynote presentations, plenary sessions, breakout discussions, and an interactive expert panel addressing the most pressing challenges in IgG4-RD—from diagnosis and treatment to long-term outcomes and patient quality of life.
Attendees will have the opportunity to engage directly with experts across specialties, reflecting the real-world, team-based approach required to care for patients with this condition.
The full agenda is outlined below.
IgG4ward! EuroJAM Agenda
View the full IgG4ward! EuroJAM Agenda
10:00 - 10:20
Welcome and Opening Remarks
Katharine Provencher / Prof John Stone (IgG4ward! Foundation) and Dr Emma Culver
10:20 - 10:55
Opening Keynote
Where Have We Come From? The History and Evolution of IgG4-related disease.
Prof John Stone
10:55 - 11:35
Plenary Session #1
Challenges in the Journey to Diagnosis: getting the diagnosis right and why it matters.
Dr Emma Culver
11:35 - 11:50
Morning Break
11:50 - 12:30
Plenary Session #2
Effective Treatments for IgG4-RD: what are the options and why do we treat?
Dr Emanuel Della Torre
12:30 - 1:30
Lunch
1:30 - 2:30
Breakout Session #1
Participants choose ONE:
Pancreas IgG4: enzyme replacement, sugar control, and nutrition
Dr Vinciane Rebours/Dr George Webster/Catherine Nash
Salivary Glands - Head and Neck IgG4: swollen glands, dryness, and oral hygiene
Dr Stephen Porter/Dr Fernando Martinez Valle
Hormone Function and Diabetes Control
Dr Florian Wernig/Jenny O'Donoghue
2:30 - 2:40
Transition Break
2:40 - 3:40
Breakout Session #2
Participants choose ONE:
Retroperitoneal Fibrosis: back pain and stents
Dr Arche Hughes-Hallett / Joana Teles
Head and Eyes IgG4: sight, balance, and walking
Dr Claire Rice / Adedoyin Dawodu
Skin IgG4: itching and rashes
Dr. Rubeta Matin/ Liane Reeves
3:40 - 3:45
Transition Break
3:45 - 4:30
Plenary Session #3
Central Concept of Teamwork and Communication in Improving Patient care: multi-disciplinary teams
Dr Emma Culver, Dr James Tomlinson, Dr Maria Leandro, Dr George Webster, Dr Florian Wernig, Dr Clair Rice, Dr Arche Hughes-Hallet, Dr Stephen Porter
Specialties include: Pancreatologist, Hepatologist, Nephrologist, Rheumatologist, Neurologist, Urologist, ENT, Dermatologist, General Internist
6.30 - 9.00
Reception and Evening Dinner
A hosted dinner with time for connection, conversation, and community building.
8:00 - 8:40
Breakfast
8:45 - 9:25
Keynote
Living with IgG4-RD Across Europe: Quality of Life, Holistic Patient Care and Networking
Dr Emanuel Della Torre/Dr José Ballarin (PAG)
9:25 - 10:15
Plenary Session #4
Clinical Trials and Clinical Research: What are they and why to enroll?
Dr Matthias Löhr/ Jenny O'Donoghue
10:15 - 10:30
Break
10:30 - 11:30
Breakout Session #3
Participants choose ONE:
B cell therapies: vaccinations, infection risk, monitoring and frequency
Dr Nicolas Schleinitz
Recognition and treatment of damage in IgG4 pancreatobiliary disease
Dr Matthias Löhr
Heart and Vessels: breathlessness, dizziness, and chest pain
Dr Nik Sabharwal
Kidney IgG4: high blood pressure and water retention
Dr James Tomlinson
11:30 - 11:40
Transition Break
11:40 - 12:40
Breakout Session #4
Participants choose ONE:
Disease Flares: monitoring and what to look out for
Dr James Tomlinson
Side effects of Medications: steroids and DMARDs - recognition and how to manage them
Dr Maria Leandro / Adedoyin Dawodu
Outcomes: what should I expect for my future?
Dr Jan van Laar
Why me, and what is the risk to my family
Dr. Nicolas Schleinitz
12:40 - 1:00
Grab-andGo Lunch/Light Fare
(Quick transition to allow for a meaningful final session)
1:00 - 2:00
Plenary Session #5
Interactive KOL Q&A Panel: Key Opinion Leaders answer questions from attendees
Dr John Stone, Dr Emma Culver, Dr Emanuel Della Torre, Dr. Nicolas Schleinitz, Dr Jan van Laar and Dr Matthias Löhr
2:00
Closing Remarks & Event Wrap-Up
Dr Emma Culver & IgG4ward! Foundation
Register for the IgG4ward! EuroJAM
The IgG4ward! EuroJAM is a shared, in-person experience dedicated to education, empowerment, and connection within the global IgG4-RD community.
We look 4ward to welcoming you to London in May 2026.